Medications

Nasal spray approved for treating suicidal people

Johnson & Johnson's Spravato has been approved as the first antidepressant for actively suicidal people, as doctors are becoming increasingly concerned about COVID-19's effect on the mental health of Americans.

Psychology & Psychiatry

Hospital study examines the cost-effectiveness of esketamine

A paper authored by researchers from McLean Hospital has determined that esketamine, a nasal spray to treat severe depression, is currently too expensive for widespread use. Titled "Cost-Effectiveness of Esketamine Nasal ...

Medications

Pain-relief drug delivers choices for mothers in labour

Choice and control are important factors for ensuring a positive childbirth experience, yet until recently, little was known about the impact of alternative administrations of fentanyl—one of the pain relief drugs used ...

Psychology & Psychiatry

New study shows how ketamine combats depression

In low doses, the anaesthetic drug ketamine has been shown to have a rapid effect on difficult-to-treat depression. Researchers at Karolinska Institutet report that they have identified a key target for the drug: specific ...

Health

Being in the wrong place can set off an allergic reaction

Allergic reactions can occur without being triggered by an allergen such as grass or birch pollen—it is enough for the patient to be back in the same place where she was previously exposed to the allergen, as researchers ...

Medical research

Worm extract found to reduce inflammation in mouse models

A team of researchers from Germany, Switzerland, Sweden and Australia has found that a substance isolated from roundworm larvae was able to reduce inflammation in the airways of mice. In their paper published in the journal ...

page 14 from 30